Loblaw Companies (TSE:L – Free Report) had its target price increased by National Bankshares from C$188.00 to C$195.00 in a research report released on Thursday,BayStreet.CA reports.
L has been the topic of several other reports. Desjardins upped their target price on Loblaw Companies from C$157.00 to C$172.00 and gave the stock a “hold” rating in a research report on Tuesday, July 23rd. TD Securities cut their price objective on Loblaw Companies from C$203.00 to C$202.00 and set a “buy” rating for the company in a research report on Thursday. BMO Capital Markets lifted their target price on Loblaw Companies from C$160.00 to C$180.00 in a research note on Friday, July 26th. Royal Bank of Canada lifted their price objective on Loblaw Companies from C$183.00 to C$205.00 in a research note on Tuesday, November 12th. Finally, CIBC lifted their price objective on Loblaw Companies from C$171.00 to C$189.00 in a research note on Friday, July 26th. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of C$191.29.
View Our Latest Stock Analysis on L
Loblaw Companies Trading Up 0.5 %
Loblaw Companies Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 30th. Investors of record on Sunday, December 15th will be issued a dividend of $0.513 per share. This represents a $2.05 annualized dividend and a dividend yield of 1.13%. Loblaw Companies’s dividend payout ratio (DPR) is 31.06%.
About Loblaw Companies
Loblaw Companies Limited, a food and pharmacy company, provides grocery, pharmacy and healthcare services, health and beauty products, apparels, general merchandise, financial services, and wireless mobile products and services in Canada. It operates in two segments, Retail and Financial Services. The Retail segment operates corporate and franchise-owned retail food, and associate-owned drug stores.
Further Reading
- Five stocks we like better than Loblaw Companies
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- Using the MarketBeat Stock Split Calculator
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Time to Load Up on Home Builders?
Receive News & Ratings for Loblaw Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Loblaw Companies and related companies with MarketBeat.com's FREE daily email newsletter.